SCHEMBL18151609

SCHEMBL18151609

CCOC(=O)Cc1cccc(S(=O)(=O)NC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
ALDH1A1 P00352 4/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HPGD P15428 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
POLB P06746 2/20 0.43
CTSG P08311 1/20 0.43
CMA1 P23946 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
AGTR1 P30556 1/20 0.42
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
AURKA O14965 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9026247 0.84 PTGS1 (0.45) TSHRALDH1A1CYP2C9CYP2C19KDM4E
SCHEMBL168002 0.84 GAA (0.49) TSHRALDH1A1CYP2C9CYP2C19MEN1
SCHEMBL2517599 0.82 LMNA (0.62) TSHRALDH1A1MEN1KMT2AKDM4E
SCHEMBL3846633 0.81 PTGDR2 (0.49) CYP2C19LMNATDP1POLBL3MBTL1
SCHEMBL28183347 0.81 NQO2 (0.45) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL68412 0.80 L3MBTL1 (0.50) ALDH1A1MEN1KMT2AL3MBTL1MAPK1
SCHEMBL19332547 0.77 GAA (0.47) TSHRALDH1A1CYP2C9CYP2C19MEN1
SCHEMBL12217548 0.77 KAT6A (0.49) ALDH1A1KMT2ALMNATDP1L3MBTL1
SCHEMBL2636349 0.77 HTT (0.45) ALDH1A1MEN1KMT2ALMNAHSD17B10
SCHEMBL1510176 0.76 POLB (0.44) TSHRALDH1A1CYP2C9CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105980353-B ROR gamma modulators 领先制药控股公司 2019-06-14 CN disclosed
EP-3077372-B1 ROR GAMMA (RORY) MODULATORS LEAD PHARMA HOLDING BV (NL) 2019-02-06 EP disclosed
US-9738600-B2 ROR gamma (RORγ) modulators LEAD PHARMA CEL MODELS IP B.V. (NL) 2017-08-22 US disclosed
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS LEAD PHARMA CEL MODELS IP B.V. (NL) 2016-10-20 US disclosed
CN-105980353-A ROR gamma modulators 领先制药CEL模型知识产权公司 2016-09-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS RORC, RORA, RORB TSHR 167/4885ALDH1A1 1054/4885CYP2C9 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.